DCOY Decoy Therapeutics Inc. - Common Stock
NASDAQ · Visualizza su SEC EDGAR ↗ chiudi Ott 2, 2026 10-K/10-Q Ago 12, 2026
$1,77
· % dell'intervallo 52 sett.
· sopra il minimo
· al massimo
$0,52minimo 52 sett.
$13,51massimo 52 sett.
Capitalizzazione di Mercato (MRQ)
$941.6K
P/E
-0.0
EPS
$-129.10
i tuoi badge
Intervallo 52 sett.
$1–$14
Rating Analisti
HOLD
Prezzo Obiettivo
$3
P/E
-0.0
ROE
·
Margine di Profitto Netto
·
La tua barra dei badge è vuota — aggiungi una metrica a piacere in questa pagina.
DCOY Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$1.77
Capitalizzazione di Mercato (MRQ)
$941.6K
P/E
-0.0
EPS
$-129.10
Intervallo 52 sett.
$1–$14
DCOY Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
intervallo
barre
La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.
Split azionari
| Data ex-dividendo | Split | Tipo |
|---|---|---|
| 09 Marzo 2026 | 1-for-12 | Inverso |
| 18 Agosto 2025 | 1-for-15 | Inverso |
| 17 Giugno 2024 | 1-for-8 | Inverso |
| 17 Ottobre 2022 | 1-for-25 | Inverso |
| 22 Luglio 2019 | 1-for-25 | Inverso |
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi·2016-12-31 → 2022-12-31
EPS$-129.102020-12-31 → 2025-12-31
Flusso di cassa libero·2016-12-31 → 2021-12-31
Margine netto·2016-12-31 → 2021-12-31
Valutazione e Rapporti
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
| Metrica | Tendenza 5 anni | DCOY | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| P/E | -0.0 | · | · | · | |
| P/B (MRQ) | 0.2 | · | · | · | |
| Price / Tangible Book (Prezzo / Valore contabile tangibile) | 0.1 | · | · | · |
La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
Nessun dato per questo gruppo di rapporti al momento
Dati fondamentali insufficienti per calcolare questo gruppo di rapporti.
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
| Metrica | Tendenza 5 anni | DCOY | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Rapporto corrente (MRQ) | 1.8 | · | · | · |
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
Nessun dato per questo gruppo di rapporti al momento
Dati fondamentali insufficienti per calcolare questo gruppo di rapporti.
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
Nessun dato per questo gruppo di rapporti al momento
Dati fondamentali insufficienti per calcolare questo gruppo di rapporti.
valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
50.4%
Prossimo report
Nov 12, 2026
| Periodo | Rapporto | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|---|
| 30 Settembre 2024 | $-136.80 | $-440.64 | 69.0% | |
| 31 Marzo 2024 | $-590.40 | $-9840.96 | 94.0% | |
| 30 Settembre 2023 | $-936.00 | $-1762.56 | 46.9% | |
| 30 Giugno 2023 | $-2059.20 | $-1904.55 | -8.1% |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | $0 | $2M | $5M | $3M | $2M | $1M | $1M | $0 | $0 | |
| Cost of Revenue | · | · | · | · | · | · | · | $430.8K | $506.5K | $662.7K | $0 | $0 | |
| R&D Expense | $368.2K | $770.0K | $7M | $16M | $9M | $7M | $4M | $1M | $17M | $20M | $13M | $4M | |
| SG&A Expense | $4M | $5M | $6M | $7M | $6M | $6M | $8M | $2M | $19M | $20M | $16M | $4M | |
| Operating Expenses | $13M | $6M | $13M | $32M | $15M | $13M | $12M | $4M | $36M | $41M | $29M | $8M | |
| Operating Income | $-13M | $-6M | $-13M | $-32M | $-13M | $-8M | $-8M | $-2M | $-35M | $-40M | $-29M | $-8M | |
| Interest Income | · | · | · | · | · | · | · | $152.0K | $292.0K | $393.1K | $72.0K | $18.9K | |
| Pretax Income | · | · | · | · | · | · | · | · | · | · | $-29M | $-8M | |
| Income Tax | $0 | · | · | · | · | · | $0 | · | · | · | · | · | |
| Net Income | $-13M | $-6M | $-13M | $-32M | $-13M | $-7M | $-7M | $-2M | $-34M | $-39M | $-29M | $-8M | |
| EPS (Basic) | $-129.10 | $-69.54 | $-30.74 | $-14.88 | $-7.72 | $-0.50 | · | · | · | · | · | · | |
| EPS (Diluted) | $-129.10 | $-69.54 | $-30.74 | $-14.88 | $-7.72 | $-0.50 | · | · | · | · | · | · | |
| Shares (Basic) | 96,967 | 80,184 | 408,078 | 2,124,511 | 1,654,638 | 15,578,611 | · | · | · | · | · | · | |
| Shares (Diluted) | 96,967 | 80,184 | 408,078 | 2,124,511 | 1,654,638 | 15,578,611 | · | · | · | · | · | · | |
| EBITDA | · | $-6M | · | $-32M | $-13M | $-8M | $-8M | · | $-35M | $-40M | · | · |
Stato Patrimoniale
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $11M | $2M | $6M | $12M | $29M | $11M | $4M | $3M | $19M | $22M | $67M | $34M | |
| Short-term Investments | · | · | · | · | · | · | · | $0 | $14M | $39M | $25M | $0 | |
| Receivables | · | · | · | · | $2M | $4M | $0 | $9.9K | $10.4K | $12.2K | $0 | · | |
| Inventory | · | · | · | · | · | · | · | $186.9K | $431.9K | $454.1K | $0 | · | |
| Prepaid Expense | $275.2K | $553.0K | $619.8K | $803.4K | $949.2K | $822.0K | $955.9K | $249.1K | $777.1K | $926.0K | $908.6K | $370.4K | |
| Other Current Assets | $275.2K | $43.7K | $151.3K | $167.6K | $173.0K | $137.8K | $136.1K | $22.3K | · | · | · | · | |
| Current Assets | $11M | $3M | $7M | $15M | $30M | $16M | $5M | $6M | $35M | $62M | $92M | $34M | |
| PP&E (Net) | $40.6K | $0 | · | · | $7.9K | $22.6K | $25.0K | $37.5K | $331.0K | $556.3K | $382.4K | $85.1K | |
| PP&E (Gross) | · | · | · | · | · | · | · | $875.6K | $953.9K | $879.3K | $442.5K | $97.1K | |
| Accum. Depreciation | · | · | · | · | · | · | · | $801.1K | $622.9K | $323.0K | $60.1K | $12.0K | |
| Goodwill | · | · | · | $0 | $9M | $9M | $9M | $0 | · | · | · | · | |
| Other Non-current Assets | $31.0K | $35.4K | $66.8K | $130.5K | $193.9K | $247.1K | $308.7K | $195.4K | $0 | $64.8K | $0 | $50.0K | |
| Total Assets | $11M | $3M | $7M | $15M | $41M | $25M | $14M | $7M | $35M | $63M | $95M | $36M | |
| Accounts Payable | $940.6K | $937.0K | $602.9K | $3M | $2M | $2M | $2M | $379.8K | $2M | $1M | $875.6K | $578.7K | |
| Short-term Debt | $0 | $221.9K | $289.6K | $0 | $0 | $477.0K | $502.3K | $0 | · | · | · | · | |
| Current Liabilities | $5M | $2M | · | · | · | · | · | $1M | $6M | $4M | $3M | $1M | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | $0 | $15.4K | $15.4K | |
| Total Liabilities | $5M | $2M | $1M | $4M | $2M | $3M | $3M | $8M | $6M | $4M | $3M | $1M | |
| Total Debt | · | $221.9K | · | · | $0 | $477.0K | $502.3K | · | · | · | · | · | |
| Common Stock | $53 | $1 | $49 | $225 | $181 | $2.4K | $451 | $203 | $1.8K | $1.7K | $1.6K | $221 | |
| Paid-in Capital | $100M | $83M | $82M | $74M | $71M | $42M | $23M | $4M | $140M | $136M | $129M | $1M | |
| Retained Earnings | $-94M | $-82M | $-76M | $-64M | $-32M | $-19M | $-12M | $-5M | $-111M | $-77M | $-37M | $-8M | |
| AOCI | · | · | · | · | · | · | · | $0 | $-1.2K | $-1.6K | $-24.7K | $0 | |
| Stockholders' Equity | $6M | $2M | $5M | $10M | $39M | $22M | $11M | $-1M | $-3M | $59M | $92M | $-7M | |
| Liabilities + Equity | $11M | $3M | $7M | $15M | $41M | $25M | $14M | $7M | $35M | $63M | $95M | $36M | |
| Shares Outstanding | 531,968 | 8,006 | 2,735 | 281,987 | 1,809,593 | 23,808,546 | 4,511,174 | 2,032,763 | 1,178,604 | 16,773,798 | 15,741,618 | 2,215,711 |
Flusso di cassa
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $7.2K | $4.4K | $10.1K | $6.7K | $19.2K | $18.1K | $127.4K | $16.9K | · | · | · | · | |
| Stock-based Comp | $219.1K | $273.7K | $524.8K | $796.8K | $559.0K | $319.4K | $751.6K | $31.0K | $4M | $7M | $7M | $1M | |
| Restructuring | · | · | · | · | · | · | · | $1M | · | · | · | · | |
| Other Non-cash | · | $772.3K | · | $13M | $2M | $-3M | $-6M | · | · | · | · | · | |
| Operating Cash Flow | $-5M | $-5M | $-13M | $-18M | $-10M | $-10M | $-12M | $4M | $-28M | $-32M | $-21M | $-6M | |
| CapEx | $577.0K | $0 | · | · | $0 | $2.6K | $0 | $0 | $113.5K | $559.4K | $265.6K | $76.1K | |
| Investing Cash Flow | $764.7K | $0 | $0 | $-2M | $0 | $-2.6K | $6M | $0 | $24M | $-12M | $-27M | $-76.1K | |
| Stock Issued | · | · | · | · | · | · | · | $3M | · | · | · | · | |
| Dividends Paid | · | · | · | · | · | $0 | $133.6K | $0 | · | · | · | · | |
| Financing Cash Flow | $12M | $1M | $7M | $2M | $28M | $18M | $4M | $1M | $2.6K | $22.1K | $81M | $40M | |
| Net Change in Cash | $8M | $-3M | $-6M | $-17M | $18M | $7M | $-2M | $6M | $-3M | $-44M | · | · | |
| Free Cash Flow | · | · | · | · | $-10M | $-10M | · | · | $-28M | $-33M | $-21M | $-7M |
Redditività
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | -696.3% | -148.8% | -238.5% | · | -2724.7% | -3946.5% | · | · | |
| Net Margin | · | · | · | · | -693.8% | -140.5% | -200.2% | · | -2701.7% | -3907.7% | · | · | |
| EBITDA Margin | · | · | · | · | -695.2% | -148.4% | -234.8% | · | -2724.7% | -3946.5% | · | · | |
| ROA | · | -116.1% | · | -113.9% | -38.8% | -37.9% | -67.6% | · | -70.1% | -49.9% | -44.6% | -45.0% | |
| ROE | · | -251.4% | · | -234.2% | -31.4% | -34.4% | -68.3% | · | -77.9% | -52.1% | -68.0% | 245.0% |
Liquidità e Solvibilità
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | · | · | · | · | · | · | · | 5.9 | 16.1 | 32.4 | 32.1 | |
| Quick Ratio | · | · | · | · | · | · | · | · | 5.7 | 15.7 | 32.1 | 31.7 | |
| Debt / Equity | · | 0.1 | · | · | 0.0 | 0.0 | 0.0 | · | · | · | · | · |
Efficienza
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | 0.0 | 0.1 | 0.3 | 0.3 | · | 0.0 | 0.0 | · | · | |
| Inventory Turnover | · | · | · | · | · | · | · | · | 1.1 | 2.9 | · | · | |
| Receivables Turnover | · | · | · | · | 0.7 | 2.7 | · | · | 113.0 | 165.9 | · | · |
Per Azione
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | $1.05 | · | $4.60 | $0.86 | $0.93 | $2.35 | · | $1.64 | $3.54 | $5.86 | $-2.95 | |
| Revenue / Share | · | · | · | $0.00 | $0.04 | · | · | · | · | · | · | · | |
| Cash Flow / Share | · | $-4.70 | · | $-8.28 | $-0.25 | · | · | · | · | · | · | · | |
| Cash / Share | · | $1.69 | · | $5.37 | $0.65 | $0.47 | $0.83 | · | $1.08 | $1.34 | $4.24 | $15.28 | |
| EPS (TTM) | $-129.10 | $-69.54 | $-30.74 | $-14.88 | $-7.72 | $-0.50 | · | · | · | · | · | · |
Tassi di Crescita
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | · | · | -64.8% | · | · | · | · | · | · | · |
Valutazione (TTM)
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | $0 | $0 | $2M | $5M | $3M | $2M | $1M | $1M | $0 | $0 | |
| Net Income TTM | $-13M | $-6M | $-13M | $-32M | $-13M | $-7M | $-7M | $-2M | $-34M | $-39M | $-29M | $-8M | |
| Market Cap | · | $40M | · | · | · | · | · | · | · | · | · | · | |
| Enterprise Value | · | $38M | · | · | · | · | · | · | · | · | · | · | |
| P/E | -0.0 | -0.4 | · | · | · | · | · | · | · | · | · | · | |
| P/B | · | 26.3 | · | · | · | · | · | · | · | · | · | · | |
| P / Tangible Book | 0.1 | 26.3 | · | · | · | · | · | · | · | · | · | · | |
| P / Cash Flow | · | -8.8 | · | · | · | · | · | · | · | · | · | · | |
| EV / EBITDA | · | -6.6 | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -19892.1% | -252.0% | · | · | · | · | · | · | · | · | · | · | |
| Payout Ratio | · | · | · | · | · | 0.00% | -1.9% | · | · | · | · | · | |
| Annual Payout | · | · | · | · | · | $0 | $133.6K | $0 | · | · | · | · |
Conto Economico
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $227.6K | · | · | · | $0 | · | · | · | · | · | · | · | · | $0 | · | $0 | |
| R&D Expense | $1M | $749.8K | $114.4K | $61.8K | $116.4K | $75.5K | $175.3K | $137.2K | $214.4K | $243.0K | $60.0K | $1M | $2M | $4M | $5M | $4M | |
| SG&A Expense | $1M | $2M | $402.2K | $833.3K | $849.2K | $2M | $1M | $869.2K | $1M | $2M | $910.7K | $1M | $2M | $2M | $2M | $2M | |
| Operating Expenses | $3M | $2M | $9M | $895.1K | $965.6K | $2M | $1M | $1M | $1M | $2M | $970.7K | $3M | $4M | $5M | $6M | $14M | |
| Operating Income | $-3M | $-2M | $-9M | $-895.1K | $-965.6K | $-2M | $-1M | $-1M | $-1M | $-2M | $-970.7K | $-3M | $-4M | $-5M | $-6M | $-14M | |
| Net Income | $-2M | $-2M | $-9M | $-873.5K | $-957.8K | $-2M | $-1M | $-972.1K | $-1M | $-2M | $-881.8K | $-2M | $-4M | $-5M | $-6M | $-14M | |
| EPS (Basic) | $-4.46 | $-4.18 | $-125.81 | $-1.81 | $-81.21 | $-240.07 | $-52.52 | $-11.38 | $-2.37 | $-3.27 | $-11.85 | $-5.21 | $-11.45 | $-2.23 | $-2.97 | $-6.41 | |
| EPS (Diluted) | $-4.46 | $-4.18 | $-125.81 | $-1.81 | $-81.21 | $-240.07 | $-52.52 | $-11.38 | $-2.37 | $-3.27 | $-11.85 | $-5.21 | $-11.45 | $-2.23 | $-2.97 | $-6.41 | |
| Shares (Basic) | 531,968 | 531,968 | · | 481,587 | 11,794 | 7,121 | · | 85,458 | 600,417 | 524,326 | · | 469,254 | 338,638 | 2,391,964 | · | 2,247,753 | |
| Shares (Diluted) | 531,968 | 531,968 | · | 481,587 | 11,794 | 7,121 | · | 85,458 | 600,417 | 524,326 | · | 469,254 | 338,638 | 2,391,964 | · | 2,247,753 | |
| EBITDA | $-3M | $-2M | · | $-895.1K | $-965.6K | $-2M | · | $-1M | $-1M | $-2M | · | $-3M | $-4M | $-5M | · | $-14M |
Stato Patrimoniale
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $8M | $8M | $11M | $5M | $794.9K | $2M | $2M | $3M | $3M | $4M | $6M | $8M | $12M | $9M | $12M | $17M | |
| Receivables | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $2M | |
| Prepaid Expense | $284.2K | $537.0K | $275.2K | $1M | $564.7K | $506.7K | $553.0K | $538.6K | $241.1K | $457.1K | $619.8K | $743.2K | $284.8K | $536.6K | $803.4K | $1M | |
| Other Current Assets | $146.1K | $305.8K | $275.2K | $80.9K | $26.5K | $61.6K | $43.7K | $119.0K | $151.6K | $178.1K | $151.3K | $83.1K | $174.4K | $156.5K | $167.6K | $248.7K | |
| Current Assets | $9M | $8M | $11M | $6M | $1M | $2M | $3M | $4M | $4M | $5M | $7M | $8M | $12M | $10M | $15M | $18M | |
| PP&E (Net) | $399.1K | $35.7K | $40.6K | · | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Goodwill | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Other Non-current Assets | $28.8K | $29.9K | $31.0K | $32.1K | $33.2K | $34.3K | $35.4K | $36.5K | $39.9K | $53.4K | $66.8K | $80.4K | $99.0K | $114.9K | $130.5K | $146.5K | |
| Total Assets | $9M | $8M | $11M | $6M | $1M | $2M | $3M | $4M | $4M | $5M | $7M | $8M | $12M | $10M | $15M | $20M | |
| Accounts Payable | $1M | $936.0K | $940.6K | $1M | $1M | $1M | $937.0K | $165.8K | $643.1K | $714.0K | $602.9K | $1M | $2M | $4M | $3M | $2M | |
| Short-term Debt | · | · | $0 | $0 | $0 | $112.2K | $221.9K | $328.8K | $0 | $116.9K | $289.6K | $459.1K | · | · | $0 | · | |
| Current Liabilities | $5M | $5M | $5M | · | · | · | $2M | · | · | · | · | · | · | · | · | · | |
| Total Liabilities | $5M | $5M | $5M | $2M | $2M | $2M | $2M | $934.6K | $1M | $1M | $1M | $2M | $4M | $4M | $4M | $3M | |
| Total Debt | · | · | · | $0 | $0 | $112.2K | · | $328.8K | $0 | $116.9K | · | $459.1K | · | · | · | · | |
| Common Stock | $53 | $53 | $53 | $94 | $213 | $208 | $1 | $144 | $64 | $431 | $49 | $394 | $335 | $246 | $225 | $224 | |
| Paid-in Capital | $103M | $101M | $100M | $90M | $84M | $84M | $83M | $83M | $82M | $82M | $82M | $82M | $81M | $75M | $74M | $74M | |
| Retained Earnings | $-99M | $-97M | $-94M | $-85M | $-85M | $-84M | $-82M | $-80M | $-79M | $-78M | $-76M | $-75M | $-73M | $-69M | $-64M | $-57M | |
| Stockholders' Equity | $4M | $4M | $6M | $4M | $-829.7K | $61.9K | $2M | $3M | $2M | $4M | $5M | $6M | $8M | $6M | $10M | $17M | |
| Liabilities + Equity | $9M | $8M | $11M | $6M | $1M | $2M | $3M | $4M | $4M | $5M | $7M | $8M | $12M | $10M | $15M | $20M | |
| Shares Outstanding | 531,968 | 531,968 | 531,968 | 944,491 | 2,127,286 | 2,081,839 | 8,006 | 1,441,157 | 641,177 | 4,314,433 | 492,304 | 3,938,433 | 3,352,069 | 2,468,297 | 2,255,899 | 2,249,371 |
Flusso di cassa
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $13.6K | $5.9K | $3.8K | $1.1K | $1.1K | $1.1K | $1.1K | $1.1K | $1.1K | $1.1K | $1.1K | $5.6K | $1.7K | $1.7K | $1.7K | $1.7K | |
| Stock-based Comp | $206.2K | $213.0K | $139.5K | $22.8K | $23.2K | $33.5K | $51.0K | $60.0K | $85.2K | $77.5K | $85.4K | $112.7K | $123.5K | $203.3K | $145.5K | $137.9K | |
| Other Non-cash | · | $-883.7K | · | · | · | $493.2K | · | · | · | $282.7K | · | · | · | $2M | · | · | |
| Operating Cash Flow | $-3M | $-3M | $-1M | $-2M | $-862.3K | $-1M | $-742.5K | $-1M | $-1M | $-1M | $-2M | $-4M | $-4M | $-3M | $-5M | $-6M | |
| Investing Cash Flow | · | · | $964.7K | $-200.0K | · | · | $0 | · | · | · | · | $0 | $0 | $0 | $0 | $0 | |
| Financing Cash Flow | $3M | $0 | $6M | $6M | $-141.2K | $545.6K | $-107.0K | $1M | $-28.2K | $-172.8K | $-169.4K | $-211.8K | $7M | $336.7K | $1 | $-85.7K | |
| Net Change in Cash | $468.5K | $-3M | $6M | $4M | $-1M | $-636.1K | $-849.5K | $11.2K | $-1M | $-2M | $-2M | $-4M | $2M | $-3M | $-5M | $-6M |
Redditività
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1155.8% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Net Margin | -1042.8% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -1155.8% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| ROA | -45.7% | -41.3% | · | -17.5% | -38.7% | -47.3% | · | -15.8% | -18.2% | -23.0% | · | -17.4% | -17.0% | -23.4% | · | -45.0% | |
| ROE | -136.0% | -112.9% | · | -24.4% | -123.9% | -92.1% | · | -21.6% | -26.4% | -37.2% | · | -21.5% | -19.7% | -27.4% | · | -48.6% |
Liquidità e Solvibilità
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.8 | 1.8 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Quick Ratio | 1.8 | 1.7 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Debt / Equity | · | · | · | 0.0 | 0.0 | 1.8 | · | 0.1 | 0.0 | 0.0 | · | 0.1 | · | · | · | · |
Efficienza
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | 0.0 | · | 0.0 | |
| Receivables Turnover | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 0.0 |
Per Azione
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $8.12 | $7.29 | · | $4.50 | $-0.39 | $0.03 | · | $2.03 | $3.70 | $0.85 | · | $1.54 | $2.51 | $2.25 | · | $7.39 | |
| Revenue / Share | $0.43 | · | · | · | · | · | · | · | · | · | · | · | · | $0.00 | · | $0.00 | |
| Cash Flow / Share | · | $-5.43 | · | · | · | $-0.71 | · | · | · | $-0.32 | · | · | · | $-1.32 | · | · | |
| Cash / Share | $15.58 | $14.70 | · | $5.09 | $0.37 | $0.86 | · | $2.28 | $5.10 | $1.01 | · | $1.92 | $3.44 | $3.76 | · | $7.48 | |
| EPS (TTM) | $-136.26 | $-213.01 | · | $-375.61 | $-385.18 | $-306.34 | · | $-28.87 | $-22.70 | $-31.78 | · | $-21.86 | $-23.06 | $-13.81 | · | $-17.41 |
Valutazione (TTM)
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Net Income TTM | $-14M | $-13M | · | $-5M | $-5M | $-6M | · | $-5M | $-6M | $-9M | · | $-18M | $-30M | $-31M | · | $-29M | |
| Market Cap | $4M | $3M | · | $3M | $29M | $24M | · | $31M | $23M | $274M | · | · | · | · | · | · | |
| Enterprise Value | · | · | · | $-1M | $28M | $22M | · | $28M | $20M | $270M | · | · | · | · | · | · | |
| P/E | -0.1 | -0.0 | · | -0.0 | -0.0 | -0.0 | · | -0.7 | -1.6 | -2.0 | · | · | · | · | · | · | |
| P/B | 0.9 | 0.9 | · | 0.8 | -34.5 | 380.6 | · | 10.6 | 9.6 | 75.0 | · | · | · | · | · | · | |
| P / Tangible Book | 0.9 | 0.9 | · | 0.8 | · | 380.6 | · | 10.6 | 9.6 | 75.0 | · | · | · | · | · | · | |
| P / Cash Flow | · | -1.2 | · | · | · | -19.9 | · | · | · | -202.3 | · | · | · | · | · | · | |
| Earnings Yield | -1895.1% | -3261.5% | · | -10234.6% | -2865.9% | -2708.6% | · | -133.7% | -63.6% | -50.1% | · | · | · | · | · | · |
Periodo più recente a sinistra · valori nulli mostrati come ·
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ricavi | · | · | · | $0 | $2M |
| Margine Operativo % | · | · | · | · | -696.3% |
| Utile netto | $-13M | $-6M | $-13M | $-32M | $-13M |
| EPS Diluito | $-129.10 | $-69.54 | $-30.74 | $-14.88 | $-7.72 |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Debito / Patrimonio Netto | · | 0.1 | · | · | 0.0 |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flusso di cassa libero | · | · | · | · | $-10M |
Proprietari istituzionali (13F)
Attività istituzionale — Q4 2025 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 5 | 1 | 2 | 0 | · |
Confrontato con Q3 2025. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata. Variazione vs trimestre precedente non mostrata: la copertura dei dichiaranti differisce troppo tra questi due trimestri per un confronto affidabile.
Attivisti e proprietari del 5%+ 10 partecipazioni
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| Elvin Lee | 27 Ottobre 2023 | · | Deposito iniziale | · | SEC |
| Persona segnalante non divulgata | 21 Febbraio 2020 | · | Deposito iniziale | · | SEC |
| Persona segnalante non divulgata | 21 Febbraio 2020 | · | Deposito iniziale | · | SEC |
| Persona segnalante non divulgata, Persona segnalante non divulgata | 29 Luglio 2019 | · | Deposito iniziale | · | SEC |
| Persona segnalante non divulgata | 29 Luglio 2019 | · | Deposito iniziale | · | SEC |
| Persona segnalante non divulgata | 29 Luglio 2019 | · | Deposito iniziale | · | SEC |
| Boston Foundation, Inc. (2) ×2 depositi | 17 Gennaio 2019 | · | Deposito iniziale | · | SEC |
| Christoph Westphal, M.D., Ph.D. ×2 depositi | 21 Dicembre 2018 | · | Deposito iniziale | · | SEC |
| Longwood Fund II, L.P., Longwood Fund III, L.P., Longwood Fund II GP, LLC, Longwood Fund III GP, LLC, Christoph Westphal, M.D., Ph.D., Richard Aldrich ×3 depositi | 26 Ottobre 2018 | · | Deposito iniziale | · | SEC |
| Longwood Fund II, L.P. (2), Longwood Fund II GP, LLC (2), Christoph Westphal, M.D., Ph.D. (2), Richard Aldrich (2), Michelle Dipp, M.D., Ph.D. (2) | 19 Febbraio 2015 | · | Deposito iniziale | Investimento passivo | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insider aziendali 33 insider · 13 dirigenti · 18 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Frederick Pierce II | Chief Executive Officer | 31 Agosto 2026 A | 34.844 | 0 | 0 | $0 |
| David J. Arthur | Chief Executive Officer | 11 Aprile 2024 A | 48.019 | 0 | 0 | $0 |
| Mark J Rosenblum | Chief Financial Officer | 31 Agosto 2026 A | 11.363 | 1 | 0 | $16.000 |
| John P. Mccabe | Chief Financial Officer | 14 Giugno 2018 A | 1.650 | 0 | 0 | $0 |
| Marina Hahn | President, Consumer | 11 Novembre 2015 A | · | 0 | 0 | $0 |
| Katharine Lindemann | Chief Operating Officer | 18 Gennaio 2017 A | · | 0 | 0 | $0 |
| Marschel Peter Klaus | Chief Business Officer | 31 Agosto 2026 A | 3.900 | 0 | 0 | $0 |
| Barbara Louise Hibner | Chief Scientific Officer | 31 Agosto 2026 A | 4.216 | 0 | 0 | $0 |
| Scott Jordan | Chief Business Officer | 18 Febbraio 2020 P | 31.609 | 0 | 0 | $0 |
| Pao-Yu Chuang | Controller | 10 Settembre 2019 A | · | 0 | 0 | $0 |
| Elizabeth Woo | SVP, Investor Relations | 17 Gennaio 2018 A | · | 0 | 0 | $0 |
| Thomas Wessel | Chief Medical Officer | 17 Gennaio 2018 A | 57.064 | 0 | 0 | $0 |
| Robert Hadfield | General Counsel & Secretary | 18 Gennaio 2017 A | · | 0 | 0 | $0 |
| Patricia G. Gauthier | Direttore | 31 Agosto 2026 A | 2.000 | 0 | 0 | $0 |
| Tess Burleson | Direttore | 31 Agosto 2026 A | 2.002 | 0 | 0 | $0 |
| William K. Mcvicar | Direttore | 31 Agosto 2026 A | 3.002 | 0 | 0 | $0 |
| Paul Lammers | Direttore | 31 Agosto 2026 A | 2.001 | 0 | 0 | $0 |
| Jonathan I Lieber | Direttore | 31 Agosto 2026 A | 2.002 | 0 | 0 | $0 |
| Arnold C Hanish | Direttore | 31 Agosto 2026 A | 3.418 | 1 | 2 | $3.732 |
| Bruce J Mccreedy Jr. | Direttore | 20 Febbraio 2024 A | 1.788 | 0 | 0 | $0 |
| Jonathan P Northrup | Direttore | 23 Marzo 2020 A | 352.713 | 0 | 0 | $0 |
| Roger D Tung | Direttore | 25 Luglio 2018 A | · | 0 | 0 | $0 |
| Michelle Stacy | Direttore | 25 Luglio 2018 A | 2.585 | 0 | 0 | $0 |
| Stuart A Randle | Direttore | 25 Luglio 2018 A | · | 0 | 0 | $0 |
| Marc D Kozin | Direttore | 25 Luglio 2018 A | 4.500 | 0 | 0 | $0 |
| Peter Barton Hutt | Direttore | 25 Luglio 2018 A | 11.675 | 0 | 0 | $0 |
| Roderick Mackinnon | Direttore | 26 Luglio 2017 A | 431.277 | 0 | 0 | $0 |
| Robert J Perez | Direttore | 26 Luglio 2017 A | · | 0 | 0 | $0 |
| Jeffrey D Capello | Direttore | 26 Luglio 2017 A | · | 0 | 0 | $0 |
| SCULLEY JOHN | Direttore | 21 Marzo 2016 P | 4.709 | 0 | 0 | $0 |
| Boston Foundation, Inc. | Proprietario del 10% | 09 Gennaio 2019 S | 1.600.000 | 0 | 0 | $0 |
| Longwood Fund II, L.P. | Proprietario del 10% | 16 Ottobre 2018 S | 0 | 0 | 0 | $0 |
| Christoph H Westphal | Proprietario del 10% | 16 Ottobre 2018 S | 0 | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Proprietà ETF Posseduto da 1 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| VXF · VANGUARD INDEX FUNDS | 0,00% | 4.034 SH | 19 Agosto 2026 | Giornaliero |
DCOY Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
rating · 6 analisti
VENDI
Target mediano
$3.00
+69,5%
0 0,0%
Acquisto forte
0 0,0%
Compra
3 50,0%
Mantieni
1 16,7%
Vendi
2 33,3%
Vendita forte
Target Price a 12 Mesi
1 analisti · 2026-10-02Target medio $3.00 +69,5%
Basso$3.00
Media$3.00
Alto$3.00
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| DCOY | · | -0.0 | · | · | · | · |
| VIVS | $4M | -0.3 | -9.0% | -10567.2% | -294.8% | · |
| APVO | $9M | -0.1 | · | · | -217.2% | · |
| ONCO | $2M | -0.1 | -67.7% | -1721.0% | -129.5% | 77.6% |
| REVB | · | · | · | · | · | · |
| SBFM | · | · | · | · | · | · |
| BRTX | $10M | -0.7 | -10.3% | -3959.4% | -547.6% | 93.4% |
| TCRT | · | -1.5 | -50.0% | · | · | · |
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Fonte: SEC 10-Q depositato Ago 12, 2026